<!DOCTYPE html>
<html lang="it">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Infografica - Linfoma e Leucemie</title>
    <script src="https://cdn.tailwindcss.com"></script>
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;600;700&family=Lexend:wght@400;600;700&display=swap" rel="stylesheet">
    <style>
        body {
            font-family: 'Inter', sans-serif;
            background-color: #fef2f2; /* red-50 */
            color: #7f1d1d; /* red-900 */
        }
        .card {
            background-color: #ffffff;
            border-radius: 0.75rem;
            box-shadow: 0 10px 15px -3px rgba(0, 0, 0, 0.1), 0 4px 6px -2px rgba(0, 0, 0, 0.05);
            transition: transform 0.3s ease, box-shadow 0.3s ease;
            border-top: 5px solid;
            display: flex;
            flex-direction: column;
            height: 100%;
        }
        .card:hover {
            transform: translateY(-5px);
            box-shadow: 0 20px 25px -5px rgba(0, 0, 0, 0.1), 0 10px 10px -5px rgba(0, 0, 0, 0.04);
        }
        .card-header {
            padding: 1rem;
            border-bottom: 1px solid #fee2e2;
            text-align: left;
            padding-left: 2rem;
        }
        .card-body {
            padding: 1.5rem 2rem;
            flex-grow: 1;
        }
        .list-item::before {
            content: '‚Ä¢';
            color: #dc2626; 
            font-weight: bold;
            display: inline-block;
            width: 1em;
            margin-left: -1em;
        }
        .key-point {
            font-weight: bold;
            color: #991b1b;
        }
        .dsa-mode {
            font-family: 'Lexend', sans-serif;
            background-color: #f8fafc !important;
            letter-spacing: 0.05em;
            line-height: 1.75;
            color: #334155;
        }
        .dsa-mode #main-header { background-color: #1e293b !important; }
        .dsa-mode #main-header a, .dsa-mode #main-header button, .dsa-mode #main-header h1 { color: #ffffff !important; }
        .dsa-mode .card { background-color: #ffffff; border: 1px solid #cbd5e1; }
    </style>
</head>
<body class="p-4 md:p-8">

    <header id="main-header" class="bg-red-800 text-white shadow-md p-4 rounded-lg mb-8 flex justify-between items-center flex-wrap">
        <a href="linfoma_leucemie_small_animals.html" class="inline-flex items-center font-bold hover:underline" data-lang-key="backToSummary">
            <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20"><path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm.707-10.293a1 1 0 00-1.414-1.414l-3 3a1 1 0 000 1.414l3 3a1 1 0 001.414-1.414L9.414 11H13a1 1 0 100-2H9.414l1.293-1.293z" clip-rule="evenodd"></path></svg>
            <span data-lang-key="backToSummaryText">Torna al Riassunto</span>
        </a>
        <div class="flex items-center space-x-4">
            <button id="accessibility-toggle" aria-label="Attiva modalit√† ad alta leggibilit√†" class="text-sm font-semibold px-3 py-2 rounded-lg bg-white/20 hover:bg-white/30 transition" data-lang-key="accessibility">Accessibilit√†</button>
            <button id="lang-toggle" aria-label="Change language" class="text-sm font-semibold px-3 py-2 rounded-lg bg-white/20 hover:bg-white/30 transition">EN</button>
        </div>
    </header>

    <div class="container mx-auto max-w-5xl">
        <header class="text-center mb-10">
            <h1 class="text-4xl md:text-5xl font-bold text-red-800" data-lang-key="pageTitle">Linfoma e Leucemie: Punti Chiave</h1>
            <p class="text-lg text-red-700 mt-2" data-lang-key="pageSubtitle">Differenze tra cane e gatto e fattori prognostici</p>
        </header>

        <div class="grid grid-cols-1 md:grid-cols-2 gap-6">
            
            <!-- Card 1: Linfoma Canino -->
            <div class="card border-red-500">
                <div class="card-header bg-red-50">
                    <h2 class="text-xl font-bold text-red-800" data-lang-key="canineTitle">1. Linfoma Canino</h2>
                </div>
                <div class="card-body">
                    <div class="flex flex-col items-center gap-4 h-full">
                        <div class="text-center text-6xl">üê∂</div>
                        <ul class="pl-4 space-y-2 text-base w-full">
                            <li class="list-item" data-lang-key="can1"><strong>Forma:</strong> Multicentrica (Linfoadenomegalia non dolente).</li>
                            <li class="list-item" data-lang-key="can2"><strong>B-cell:</strong> Prognosi MIGLIORE ("B is Better").</li>
                            <li class="list-item" data-lang-key="can3"><strong>T-cell:</strong> Prognosi PEGGIORE + Ipercalcemia ("T is Terrible").</li>
                        </ul>
                    </div>
                </div>
            </div>

            <!-- Card 2: Linfoma Felino -->
            <div class="card border-orange-500">
                <div class="card-header bg-orange-50">
                    <h2 class="text-xl font-bold text-orange-800" data-lang-key="felineTitle">2. Linfoma Felino</h2>
                </div>
                <div class="card-body">
                    <div class="flex flex-col items-center gap-4 h-full">
                        <div class="text-center text-6xl">üê±</div>
                        <ul class="pl-4 space-y-2 text-base w-full">
                            <li class="list-item" data-lang-key="fel1"><strong>Forma:</strong> Alimentare (Intestinale) pi√π comune oggi.</li>
                            <li class="list-item" data-lang-key="fel2"><strong>Small Cell (Low Grade):</strong> Cronico, ottima sopravvivenza (>2 anni).</li>
                            <li class="list-item" data-lang-key="fel3"><strong>Large Cell (High Grade):</strong> Aggressivo, prognosi riservata.</li>
                        </ul>
                    </div>
                </div>
            </div>

            <!-- Card 3: Leucemie -->
            <div class="card border-blue-500">
                <div class="card-header bg-blue-50">
                    <h2 class="text-xl font-bold text-blue-800" data-lang-key="leukTitle">3. Leucemie</h2>
                </div>
                <div class="card-body">
                    <div class="flex flex-col items-center gap-4 h-full">
                        <div class="text-center text-6xl">ü©∏</div>
                        <ul class="pl-4 space-y-2 text-base w-full">
                            <li class="list-item" data-lang-key="leuk1"><strong>Acuta (ALL/AML):</strong> BLASTI immaturi. Decorso rapido, prognosi infausta.</li>
                            <li class="list-item" data-lang-key="leuk2"><strong>Cronica (CLL):</strong> Linfociti MATURI. Decorso lento, spesso asintomatica.</li>
                        </ul>
                    </div>
                </div>
            </div>

             <!-- Card 4: Terapia -->
            <div class="card border-green-500">
                <div class="card-header bg-green-50">
                    <h2 class="text-xl font-bold text-green-800" data-lang-key="therapyTitle">4. Terapia</h2>
                </div>
                <div class="card-body">
                    <div class="flex flex-col items-center gap-4 h-full">
                        <div class="text-center text-6xl">üíä</div>
                        <ul class="pl-4 space-y-2 text-base w-full">
                            <li class="list-item font-bold text-green-700" data-lang-key="ther1">Gold Standard: Protocollo CHOP</li>
                            <li class="list-item text-sm" data-lang-key="ther2">(Ciclofosfamide, Doxorubicina, Vincristina, Prednisolone).</li>
                            <li class="list-item text-sm" data-lang-key="ther3">Obiettivo: Prolungare la sopravvivenza.</li>
                        </ul>
                    </div>
                </div>
            </div>

        </div>

        <footer class="text-center mt-16 pt-8 border-t border-red-100">
             <p class="text-slate-500" data-lang-key="footer-credit">A cura della Prof.ssa Sara Busechian. Insegnamenti di clinica medica veterinaria</p>
        </footer>
    </div>

    <script>
        document.addEventListener('DOMContentLoaded', () => {
            const translations = {
                backToSummaryText: { it: "Torna al Riassunto", en: "Back to Summary" },
                accessibility: { it: "Accessibilit√†", en: "Accessibility" },
                pageTitle: { it: "Linfoma e Leucemie: Punti Chiave", en: "Lymphoma and Leukemias: Key Points" },
                pageSubtitle: { it: "Differenze tra cane e gatto e fattori prognostici", en: "Differences between dog and cat and prognostic factors" },
                
                canineTitle: { it: "1. Linfoma Canino", en: "1. Canine Lymphoma" },
                can1: { it: "<strong>Forma:</strong> Multicentrica (Linfoadenomegalia non dolente).", en: "<strong>Form:</strong> Multicentric (Non-painful lymphadenomegaly)." },
                can2: { it: "<strong>B-cell:</strong> Prognosi MIGLIORE ('B is Better').", en: "<strong>B-cell:</strong> BETTER prognosis ('B is Better')." },
                can3: { it: "<strong>T-cell:</strong> Prognosi PEGGIORE + Ipercalcemia ('T is Terrible').", en: "<strong>T-cell:</strong> WORSE prognosis + Hypercalcemia ('T is Terrible')." },

                felineTitle: { it: "2. Linfoma Felino", en: "2. Feline Lymphoma" },
                fel1: { it: "<strong>Forma:</strong> Alimentare (Intestinale) pi√π comune oggi.", en: "<strong>Form:</strong> Alimentary (Intestinal) most common today." },
                fel2: { it: "<strong>Small Cell (Low Grade):</strong> Cronico, ottima sopravvivenza (>2 anni).", en: "<strong>Small Cell (Low Grade):</strong> Chronic, excellent survival (>2 years)." },
                fel3: { it: "<strong>Large Cell (High Grade):</strong> Aggressivo, prognosi riservata.", en: "<strong>Large Cell (High Grade):</strong> Aggressive, guarded prognosis." },

                leukTitle: { it: "3. Leucemie", en: "3. Leukemias" },
                leuk1: { it: "<strong>Acuta (ALL/AML):</strong> BLASTI immaturi. Decorso rapido, prognosi infausta.", en: "<strong>Acute (ALL/AML):</strong> Immature BLASTS. Rapid course, grave prognosis." },
                leuk2: { it: "<strong>Cronica (CLL):</strong> Linfociti MATURI. Decorso lento, spesso asintomatica.", en: "<strong>Chronic (CLL):</strong> MATURE lymphocytes. Slow course, often asymptomatic." },

                therapyTitle: { it: "4. Terapia", en: "4. Therapy" },
                ther1: { it: "Gold Standard: Protocollo CHOP", en: "Gold Standard: CHOP Protocol" },
                ther2: { it: "(Ciclofosfamide, Doxorubicina, Vincristina, Prednisolone).", en: "(Cyclophosphamide, Doxorubicin, Vincristine, Prednisolone)." },
                ther3: { it: "Obiettivo: Sopravvivenza.", en: "Goal: Survival." },

                "footer-credit": { it: "A cura della Prof.ssa Sara Busechian. Insegnamenti di clinica medica veterinaria", en: "Curated by Prof. Sara Busechian. Veterinary clinical medicine teachings" }
            };

            let currentLanguage = localStorage.getItem('language') || 'it';

            function updateLanguage(lang) {
                document.documentElement.lang = lang;
                document.getElementById('lang-toggle').textContent = lang === 'it' ? 'EN' : 'IT';
                document.querySelectorAll('[data-lang-key]').forEach(element => {
                    const key = element.dataset.langKey;
                    if (translations[key] && translations[key][lang]) {
                        element.innerHTML = translations[key][lang];
                    }
                });

                const dsaToggle = document.getElementById('accessibility-toggle');
                if (document.body.classList.contains('dsa-mode')) {
                    dsaToggle.textContent = lang === 'it' ? 'Vista Standard' : 'Standard View';
                } else {
                    dsaToggle.textContent = lang === 'it' ? 'Accessibilit√†' : 'Accessibility';
                }
            }
            
            document.getElementById('lang-toggle').addEventListener('click', () => {
                currentLanguage = currentLanguage === 'it' ? 'en' : 'it';
                localStorage.setItem('language', currentLanguage);
                updateLanguage(currentLanguage);
            });

            const dsaToggle = document.getElementById('accessibility-toggle');
            dsaToggle.addEventListener('click', () => {
                document.body.classList.toggle('dsa-mode');
                if (document.body.classList.contains('dsa-mode')) {
                    dsaToggle.textContent = currentLanguage === 'it' ? 'Vista Standard' : 'Standard View';
                } else {
                    dsaToggle.textContent = currentLanguage === 'it' ? 'Accessibilit√†' : 'Accessibility';
                }
            });

            updateLanguage(currentLanguage);
        });
    </script>
</body>
</html>
